ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬27”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹Æ

•½¬27”N“xƒGƒCƒY‘ÎôŒ¤‹†Ž–‹ÆŽ–‘O•]‰¿ˆÏˆõ–¼•ë

i›FˆÏˆõ’·j

‰ªè@—ߎ¡ –¼ŒÃ‰®‘åŠw•ªŽq¶•¨ŠwŒ¤‹†Ž{Ý‹³Žö
•ªŽq¶•¨Šw
ƒŒ¤‹†˜_•¶—á„
Mechanism of DNA chain growth. I. Possible discontinuity and unusual secondary structure of newly synthesized chains. Okazaki R, Okazaki T, Sakabe K, Sugimoto K, Sugino A. Proc Natl Acad Sci USA. 1968 Feb; 59(2): 598-605.
ƒ’˜ì—á„
uŠâ”guÀŒ»‘ã‚̶•¨Šw@‘æ‚RŠªFˆâ“`v‰ªè—ߎ¡‘¼‹¤’˜, Šâ”g‘“X, (1967).
ƒŠwp“I”­•\—á„
In vivo mechanism of DNA chain growth OKAZAKI, R., T. OKAZAKI, K. SAKABE, K. SUGIMOTO, R. KAINUMA, A. SUGINO, and N. IWATSUKI, Cold Spring Harbor Symposium, 1968
 
’rã@çŽõŽq “Á’è”ñ‰c—˜Šˆ“®–@l‚Õ‚ê‚¢‚·“Œ‹ž—Ž–
ƒZƒNƒ\ƒƒW[
u«‚ɂ‚¢‚ÄŒê‚낤@Žq‚Ç‚à‚ƈê‚Él‚¦‚év’rãçŽõŽq’˜AŠâ”gƒuƒbƒNƒŒƒbƒgA2013
uŽv‚¢‚±‚Ý‚Ì«AƒŠƒXƒL[‚ȃZƒbƒNƒXv’rãçŽõŽq’˜AŠâ”g‘“XA2011
u21¢‹I‚̉ۑ衂±‚»AƒGƒCƒY‚ðl‚¦‚év’rãçŽõŽq’˜@à’c–@l“ú–{«‹³ˆç‹¦‰ï@«‹³ˆçƒnƒ“ƒhƒuƒbƒNvol.5 2011
 
¡‘º@’m–¾ “Þ—ÇŒ§—§ˆã‰È‘åŠw‹³Žö
ŒöO‰q¶ŠwAŒ’N­ôˆãŠwAˆã—íô
‚`‚h‚c‚r^Š´õŽÒV‹K•ñ”ä—¦|‚¢‚í‚ä‚éu‚¢‚«‚È‚è‚`‚h‚c‚r—¦v|‚ÌŒŸ“¢. ¬ìr•vA”’â‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2012 Feb;14(1):46-54.
‚g‚h‚uf—ÂɊւí‚錴‰¿‚ÌŽÀ‘Ô’²¸. ˆäo”Ž¶AÔ‰HŠwA”’ã‘ô–A¡‘º’m–¾. “ú–{ƒGƒCƒYŠw‰ïŽ. 2010 Feb;12(1):49-55.
History of public health crises in Japan. Imamura T, Ide H, Yasunaga H. J Public Health Policy. 2007 Nov;28(2):221-237
 
Šâ–{@ˆ¤‹g ‘—§Œ¤‹†ŠJ”­–@l “ú–{ˆã—ÃŒ¤‹†ŠJ”­‹@\ ‰ÈŠw‹ZpŒÚ–â
HIVŠ´õÇAŠ´õÇ“à‰ÈAƒEƒCƒ‹ƒXŠw
Switching and emergence of CTL epitopes in HIV-1 infection. Han, C., Kawana-Tachikawa, A., Shimizu, A., Zhu, D., Nakamura, H., Adachi, E., Kikuchi, T., Koga, M., Koibuchi, T., Gao, GF., Sato, Y., Yamagata, A., Martin, E., Fukai, S., Brumme, ZL., and Iwamoto, A. Retrovirology 11:38, 2014.  doi:10.1186/1742-4690-11-38, 2014. (Published May 21, 2014).
Structure of TCR and antigen complexes at an immunodominant CTL epitope in HIV-1 infection. Shimizu, A., Kawana-Tachikawa, A., Yamagata, A., Han, C., Zhu, D., Sato, Y., Nakamura, H., Koibuchi, T., Carlson, J., Martin, E., Brumme, C.J., Shi, Y., Gao, G.F., Brumme, Z.L., Fukai, S., and Iwamoto, A. Sci. Rep. 3: 3097, 2013; doi: 10.1038/srep03097(2013).
Development of a Rapid Cell-Fusion-based Phenotypic HIV-1 Tropism Assay. Teeranaipong, P., Hosoya, N., Kawana-Tachikawa, A., Fujii, T., Koibuchi, T., Nakamura, H., Koga, M., Kondo, N., Gao, G.F., Hoshino, H., Matsuda, Z., and Iwamoto, A. Journal of the International AIDS Society 16:18723, 2013.
 
¬–쎛@ºˆê •xŽmŽs—§’†‰›•a‰@E‰@’·A“Œ‹žŽœŒb‰ïˆã‰È‘åŠw‹qˆõ‹³Žö
”å”AŠí‰ÈA”A˜HE«ŠíŠ´õÇAŠ´õ§Œä
Comparison of free and anonymous testing for HIV and sexually@transmitted infections between the University Hospital and Health@Center. Yoshida M, Chiba A, Kawano S, Kato T, Sato F, Horino T, Nakazawa Y, Yoshikawa K, Onodera S, Hori S. J Infect Chemother. 2012 Mar 23.[Epub ahead of print]
HIVŠ´õŽÒ‚Ì”~“Å‚ÉŠÖ‚·‚錟“¢.²“¡•¶Æ,‰Í–ì^“ñ,‰Á“¡“N˜N,–x–ì“N–ç,’†àV –õ,‹gìWŽi,‹g“c³Ž÷,¬–쎛ºˆê.“ú«Š´õljïŽ20i1jF2009F192-197.
¬–쎛ºˆêFŒú¶˜J“­‰ÈŠwŒ¤‹†•â•‹à VŒ^ƒCƒ“ƒtƒ‹ƒGƒ“ƒU“™V‹»EÄ‹»Š´õÇŒ¤‹†Ž–‹Æu«Š´õÇ‚ÉŠÖ‚·‚é—\–hAŽ¡—Â̑̌n‰»‚ÉŠÖ‚·‚錤‹†viŒ¤‹†‘ã•\ŽÒF¬–쎛ºˆêj•½¬21”N“x`•½¬23”N“x‘‡Œ¤‹†•ñ‘
‘q“c@‹B ‘Ûˆã—ÕŸŽƒ‘åŠw‰–’J•a‰@@’†‰›ŒŸ¸•”’·
ƒEƒCƒ‹ƒXŠ´õÇ‚Ì”­Ç•a—Šw
–UŒŸ—á‚©‚ç‚Ý‚½“ú–{‚̃GƒCƒY
‘q“c‹BA¬’r·—YAX–ΗY•Ò’˜
Œú¶˜J“­È‰ÈŠwŒ¤‹†”ï‚É‚æ‚錤‹†•ñ‘A•½¬5”N8ŒŽ
Topoisomerase 1 and ATP activate DNA synthesis of human immune-Deficiency virus type 1(HIV-1). BBRC294:509-517, 2002.
Takahashi H., Sawa H., Hasegawa H., Shoya Y., Sata T.,@Hall WW., Nagashima K., and Kurata T.i˜A‘±3•Òj
•aŒ´×‹Û|ƒEƒCƒ‹ƒX}ŠÓ
•Ò’˜@V‹Žu˜YA‘q“c‹BA—щp¶A–{“c•ŽiA¬“chA¼–{–¾@
–k‘åo”ʼnï@2017
 
‘ŠŠy@—TŽq Š‘®‚È‚µ
—Õ°Š´õÇŠw
“ˆ‹MŽqC{“¡O“ñC‹ß“¡^‹KŽqC‘qˆä‰ØŽqC‘ŠŠy—TŽqC¡ˆäŒõMFŒuŒõy‘f–Ɖu‘ª’è–@‚É‚æ‚éV‚µ‚¢HIVRŒ´R‘Ì“¯ŽžŒŸoŽŽ–òi‘æ4¢‘ãj‚ÌŒŸ“¢DŠ´õÇŠw‰ïŽ81F562-572C2007
’ËŒ´—DŒÈC‘ŠŠy—TŽqCŠì‘½P˜aC“ˆ‹MŽqC–î‰i—R—ŽqCŠO쳶C‘å‹à”ü˜aCˆî—tŒ›”VF‘æ20‰ñ“ú–{ƒGƒCƒYŠw‰ïƒVƒ“ƒ|ƒWƒEƒ€ Š´õ—«‚Ì”DPEoŽYEˆçŽ™Žx‰‡D“ú–{ƒGƒCƒYŠw‰ïŽ9F116-119C2007D
Mohri S, Yoshikawa K, Sagara H, Nakajima, HFA case of Penicillium marneffei infection in an AIDS patient -the first case in Japan-. Jpn J
Med Mycol 41: 23-26, 2000.
 
‹{“c@ˆê—Y ƒGƒCƒY—\–hà’c—Ž–
î•ñAŒ[”­
wNO TIME TO LOSE iƒm[Eƒ^ƒCƒ€EƒgƒDEƒ‹[ƒYj\ ƒGƒ{ƒ‰‚ƃGƒCƒY‚Æ‘Û­Ž¡xƒs[ƒ^[EƒsƒIƒbƒgi‹{“cˆê—YE’Mˆä³‹`E‘呺•üŽq–ójŒcœä‹`m‘åŠwo”ʼnï 2015”N
wVƒGƒCƒY—\–hŽwj‚ÆŽ„‚½‚¿xi•Ò’˜j ƒGƒCƒY—\–hà’c•Òi‹{“cˆê—YE‰iˆÕŽŠ•¶j ˜A‡o”Å 2012”N
w¢ŠE‚̓GƒCƒY‚Æ‚Ç‚¤“¬‚Á‚Ä‚«‚½‚Ì‚©x ‹{“cˆê—Y ƒ|ƒbƒgo”Å 2002”N

ƒz[ƒ€ > ­ô‚ɂ‚¢‚Ä > •ª–ì•Ê‚Ì­ôˆê—— > ‘¼•ª–ì‚ÌŽæ‚è‘g‚Ý > Œ¤‹†Ž–‹Æ > •½¬27”N“x@Œú¶˜J“­‰ÈŠwŒ¤‹†‚ÌŠT—v > Ž–‘O•]‰¿ˆÏˆõ‰ï–¼•ë > ƒGƒCƒY‘ÎôŒ¤‹†Ž–‹Æ

ƒy[ƒW‚Ì擪‚Ö–ß‚é